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Early diagnosis of lung cancer (LC) is a policy priority. However, symptoms are vague, 
associated with other morbidities, and frequently unrecognised by both patients and 
general practitioners (GPs). This qualitative study, part of a larger mixed methods 
study, explored GP views regarding the potential for early diagnosis of LC within pri-
mary care. Five focus group discussions (FGDs) were conducted with GPs (n = 16) at 
primary care practices (n = 5) across four counties in south England. FGDs were audio- 
recorded, transcribed verbatim and analysed using a framework approach. Four broad 
themes emerged: patients’ reporting of symptoms; GP response to symptoms; investi-
gating LC, and; potential initiatives for early diagnosis. GPs reported they often re-
quired high levels of suspicion to refer patients on to specialist respiratory consultations, 
and concerns of ‘system overload’ were prevalent. Greater access to more sensitive 
diagnostic investigations such as computed tomography, was argued for by some, par-
ticularly for symptomatic patients with negative chest X- rays. GPs challenged current 
approaches to promoting earlier diagnosis through national symptom awareness cam-
paigns, arguing instead that interventions targeted at high- risk individuals might be 
more effective without burdening services already under pressure. Further work is 
needed to identify primary care patients who might most benefit from such targeted 
interventions.
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1  | INTRODUCTION
Lung cancer is the second most common cancer in the UK, with 
45,500 new diagnoses per year (Cancer Research UK, 2016), and 
two- thirds only diagnosed at late stage when curative options are 
limited (Hamilton, Peters, Round, & Sharp, 2005). One and 5- year 
survival rates compare unfavourably with other European countries 
(Berrino et al., 2007; Coleman et al., 2011; De Angelis et al., 2014), 
and evidence suggests this disparity may be partly influenced by the 
UK’s structure of primary care provision (Rose et al., 2015). Symptoms 
associated with lung cancer are also manifestations of other common 
comorbidities amongst smokers/ex- smokers (NICE, 2015), making 
diagnosis difficult (Bowen & Rayner, 2002). The “symptom signa-
ture” of lung cancer is “harder to suspect” than other tumour sites 
for general practitioners (GPs), with 30% of patients subsequently 
diagnosed	with	 lung	 cancer	undergoing	multiple	 (≥3)	 consultations	
prior to diagnosis (Lyratzopoulos, Wardle, & Rubin, 2014). GPs typ-
ically encounter around one new presentation of lung cancer every 
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8 months, giving relatively little experience in diagnosis (Hamilton 
et al., 2005).
Recent initiatives have sought to improve early diagnosis of lung 
cancer. For example, the national “Be Clear on Cancer: 3- week cough” 
campaign was conducted in England between April and June 2012, 
with a reported significant increase in diagnoses on the same period 
in the previous year (Ironmonger et al., 2015). This increased diagnosis 
rate was accompanied, however, by corresponding increases in addi-
tional workload, over which GPs had little control (PULSE 2014).
To promote earlier diagnosis of lung cancer without overloading 
services already under pressure, we need to explore ways to shorten 
the intervals between the patient first noticing and appraising potential 
symptoms as requiring clinical attention and then seeking help from 
their GP, while also promoting the symptoms most favourable for GPs 
to investigate appropriately. This study was part of a mixed methods in-
vestigation of symptomatology and help- seeking behaviour among pri-
mary	care	patients	at	high-	risk	(≥50	years	old,	recent	smoking	history)	
(Wagland et al., 2016). We found a high prevalence among participants 
of both symptoms associated with lung cancer and comorbidities that 
manifested similar symptoms. Almost half of the participants reported 
symptoms associated with lung cancer in a questionnaire for whom 
we found from a clinical notes review did not consult their GP. We 
also identified a small, clinically relevant group of patients (n = 61/908, 
6.7%) who reported experiencing symptoms associated with lung can-
cer,	but	whom	we	found	had	not	consulted	their	GP	for	≥12	months	
(Wagland et al., 2016). The aim of the qualitative element of the study 
reported here was to explore the views of GPs regarding how best gen-
eral practice might facilitate timely diagnosis of lung cancer.
2  | METHODS
2.1 | Setting and sample
Focus group discussions (FGDs) were used for data collection as they ex-
plore collective rather than individual experiences and reveal the nature 
and variety of participants’ views (Krueger & Casey, 2000). Participants 
were drawn from five primary care practices across four counties within 
southern England. Recruitment of practices was facilitated by close col-
laboration with the Primary Care Research Network, to ensure a repre-
sentative range of practice size and social deprivation. FGDs took place 
between April and August 2014 within the practice premises of collabo-
rating GPs, and lasted 1–2 hr (mean: 1 hr 25 min). An experienced quali-
tative researcher (RW) conducted the focus groups as moderator, with a 
second researcher (AI- E) acting as observer and note- taker.
2.2 | Materials
An interview topic guide was developed to elicit participants’ views re-
garding specific symptoms, symptom combinations, severity and chro-
nicity of symptoms reported by patients that would raise suspicions 
of lung cancer. GPs gave their views regarding the importance of nine 
symptoms experienced by patients subsequently diagnosed with lung 
cancer, which comprise the IPCARD (Identifying Symptom Predictors 
of Chest and Respiratory Disease) questionnaire (Brindle et al., 2015). 
IPCARD, developed by members of the research team (Brindle et al., 
2015), asks individuals about the following symptoms in lay terms to 
facilitate elicitation: tiredness; breathing changes; chest and upper body 
aches; cough; coughing up blood; non- menopausal sweats; ongoing 
voice changes; unintentional weight loss; and noticeably more chest in-
fections over a 12- month period. GPs were informed of the preliminary 
findings from the survey and clinical notes review from the wider study 
(Wagland et al., 2016). Their views regarding perceived barriers and fa-
cilitators to early diagnosis were then explored and practical considera-
tions of administering interventions to encourage primary care patients 
to consult for symptoms potentially indicative of lung cancer.
2.3 | Analysis
Focus group discussions were transcribed verbatim and analysed 
using the computer programme Nvivo10 for assistance in structur-
ing a framework analysis (Ritchie & Lewis, 2003). Framework analy-
sis aims at facilitating applied research and its requirements to meet 
specific information needs and actionable outcomes and is conducted 
through a series of stages. The focus group moderator led the analysis, 
ensuring deep familiarisation with the data.
To facilitate data analysis, three researchers (RW, EJ, AIE) inde-
pendently analysed one FGD and discussed findings with the full re-
search team to agree upon an index of emerging themes. Thereafter, 
regular 2- weekly discussions took place between the three research-
ers to review the development of a thematic framework and ensure 
analytical rigour. A thematic framework was developed, initially drawn 
from the topic guide, to identify the key concepts central to the symp-
tomology associated with identifying patients with lung cancer, judg-
ing symptom severity and the potential for early diagnosis. During the 
analysis, other categories were derived from the data, including cri-
tiques of national symptom awareness campaigns; issues related to 
investigating lung cancer and fatalistic attitudes amongst some GPs.
The whole data set was then indexed according to these cat-
egories (indexing) and comparisons made both within and between 
them according to their thematic content, and data within categories 
summarised (charting). Relationships and associations between the 
categories were then identified (mapping and interpretation) that ex-
plained GPs’ views regarding the facilitation of timely diagnosis of lung 
cancer during the diagnostic interval.
2.4 | Ethical approval
Ethical approval for the study was secured by the National Research 
Ethics Service (NRES) Committee South Central- Southampton A on 
20/05/2012 (12/SC/0049).
3  | RESULTS
In total, 16 GPs and two practice nurses participated in the five FGDs, 
and each comprised between three and five participants (Table 1). 
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Participant GPs had a range of between 4 and 31 years in general 
practice (mean: 18.5 years). Practice sizes ranged between 3,430 and 
11,670 (mean: 7,486), and represented areas of both higher and lower 
social deprivation (range of Index of Multiple Deprivation scores: 
24.4–10.0).
Four broad themes emerged from the data: patients’ reporting of 
symptoms; GPs response to specific symptoms; issues related to in-
vestigating suspected lung cancer, and; issues related to the potential 
effectiveness of early diagnosis interventions (Table 2).
3.1 | Patients’ reporting of symptoms
The subjective nature of symptom experience made appraising the se-
verity and seriousness of symptoms reported by patients difficult for 
GPs, especially for symptoms such as fatigue and chest pain for which 
limited objective measurements exist. GPs described how many older 
patients with smoking histories had several comorbidities, and as the 
extract below illustrates, GPs recognised that consequently those pa-
tients often believed it was normal to experience symptoms such as 
cough, fatigue and breathlessness, and consequently did not report 
them even when they worsened.
GP1: Until you ask the question, [patients] change their 
boundaries of what they do, to accommodate how they 
feel. They’re not actually aware sometimes that their 
shortness of breath has got worse, they just don’t walk 
so far, or they don’t do this or that, and until you actually 
ask the question, they wouldn’t come and see you because 
they’re not aware of it.
GP2: They didn’t think it was a problem, they just changed 
the way that they live their lives, because I find that with 
COPD patients, … They don’t think they’re any worse than 
they were a year before, but when you actually ask that 
question, they’re quite considerably worse but they’re not 
aware of it.
GP1: It’s actually asking the question rather than waiting 
for them to present with a problem that they don’t per-
ceive as a problem.
GP3: And indeed, people who are retired, suddenly doing 
less functional activity, therefore they may not notice some 
of these symptoms. So obviously a lot of them don’t go out 
of the house, or go out exercising or putting themselves 
under sort of pressure to do any activity which might bring 
out some of these symptoms. Whereas, if you’re still at 
work or whatever, I suppose you might find tiredness and 
breathlessness might limit what you’re doing during the 
day, and might be more of a functional problem that you’d 
come to see a doctor about. (FGD 2)
As the extract above also indicates, patients sometimes failed to 
recognise symptoms and unless GPs specifically asked about certain 
TABLE  1 Focus group participants: gender and years in practice
Focus group Practice size
Index of Social 
deprivation
Participants
Gender Occupation Years in practice
FG1 (n = 5) 7,870 19.1 Male GP 4
Male GP 6
Female GP 22
Male GP 25
Female Practice Nurse 12
FG2 (n = 3) 6,400 10.0 Male GP 18
Female GP 26
Male GP 31
FG3 (n = 3) 11,670 24.4 Male GP 19
Male GP 26
Male GP 30
FG4 (n = 4) 8,060 12.8 Male GP 4
Male GP 16
Female GP 25
Male GP 30
FG5 (n = 3) 3,430 15.1 Male GP 6
Male GP 9
Female Practice Nurse 8
Total/mean 7,486 297/18.5
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symptoms, such as voice changes, patients were unlikely to report them. 
In addition, GPs reported that smokers often experienced guilt for symp-
toms deemed “self- inflicted”, and were consequently reluctant to report 
them to GPs. The reported duration and severity of symptomology by 
patients was often vague and reported differently between consultations 
(the story changes), further complicating diagnosis.
3.2 | GP response to specific symptoms
NICE guidelines (NICE, 2005; NICE, 2015) recommend an urgent 
chest X- ray (CXR) for patients with the following symptoms: un-
explained haemoptysis; cough; fatigue; shortness of breath; chest 
pain, and; weight loss. The guidelines also recommend CXRs be of-
fered to patients who present with recurrent chest infection. During 
FGDs, GPs were asked about two additional symptoms incorporated 
within IPCARD and potentially indicative of lung cancer: ongoing 
voice changes and non- menopausal sweating (Brindle, Pope, Corner, 
Leydon, & Banerjee, 2012). GPs were asked to consider their expe-
rience of reviewing patients with these symptoms and the relative 
weight they gave to each symptom (see Table 3).
General practitioners considered many of these as “red flag” symp-
toms, but breathing changes, repeated chest infections, unintentional 
TABLE  2 Thematic coding framework
Theme Category
Patients 
reporting of 
symptoms
Subjectivity of patient symptom experience
Patient symptom “stories” change between 
consultations
Difficulty eliciting symptoms
Patients do not always recognise symptoms
Patients do not always report symptoms
Patients often perceive symptoms as normal
GP response to 
symptoms
Identifying “alarm” Symptoms for lung cancer
Importance of GP hunch/gut instinct
Difficulty judging severity of symptoms 
experienced
Previous non- attendance at GP practice as an 
“alarm” symptom
Investigating for 
lung cancer
Low threshold of suspicion for ordering chest 
X- rays
Chest X- ray as a “blunt instrument”
High threshold of suspicion required for onward 
referral
Need for greater diagnostic tools (eg, CT 
scanning)
Potential for 
early diagnosis
Fatalist attitude amongst GPs
Critique of national symptom awareness 
campaigns
Preference for practice- led targeted interventions 
over national awareness campaigns
Preference for interventions targeting patient 
types rather than particular symptoms
TABLE  3 GP perspectives on nine symptoms potentially 
indicative of lung cancer
Symptom Views of GPs
Tiredness Non- specific symptom. Very common in 
general practice
Tiredness alone is “almost never of 
significance”
Perceived to be an “early” symptom
Other symptoms experienced more acutely by 
patients if combined with tiredness
Other symptoms are viewed more seriously if 
combined with tiredness
Cough High prevalence expected due to of COPD 
amongst many ex- /smokers population group
Patients often think it is normal for smokers to 
have a cough
Cough may last for 4–6 weeks post- viral chest 
infection
Only	chronic	cough	(≥6	weeks)	in	the	absence	
of recent infection would concern GPs
Breathing changes Breathlessness a “fairly ubiquitous” symptom
Progressively worse breathlessness a good 
indicative symptom of lung cancer
Usually a late symptom, patients with lung 
cancer rarely present with it as a first symptom
Older/inactive patients are less aware of their 
breathlessness/consider it normal
Sweats Patients rarely present with sweats alone
Important symptom when combined with 
cough
An important symptom only if sweating is 
“profuse”/“drenching”
Chest infections “Red flag” symptom if patient recently 
experienced many infections that do not settle
A late sign of lung cancer
Unintentional 
weight loss
Always seen as a “red flag” symptom if sudden 
and significant
Seen as a late symptom – “usually too late for 
survival”
Diagnosis difficult if experienced as only 
symptom, as indicative of any tumour type
Chest pain Patients subsequently diagnosed with lung 
cancer rarely present with chest pain
Perceived as a “very late” symptom
Often musco- skeletal in origin, subsequent to 
coughing
Voice changes Most common with laryngeal cancer
Patients rarely present with this symptom
GPs would refer anyone with dysphonia
Haemoptysis Always a “red flag” symptom
Refer for CXR immediately
Seen as a “very late” symptom
Sometimes caused by coughing
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weight loss, chest pain and haemoptysis were all perceived as usually 
late symptoms when lung cancer is advanced. Breathing changes and 
tiredness were thought to be fairly ubiquitous of many illnesses, and 
tiredness, although a possible early sign of lung cancer, was thought 
to be almost never of significance on its own. However, GPs believed 
patients often experience other symptoms more severely when ac-
companied by tiredness, and GPs would tend to take other symptoms 
more seriously when accompanied by tiredness. Non- menopausal 
sweats were identified as important only if they were what GPs indi-
cated as profuse or drenching sweats. While participants reflected that 
patients rarely consulted for voice changes, they thought the symp-
tom more common of laryngeal than lung cancer. Participants indi-
cated that of the nine symptoms about which they were asked, those 
considered of most concern if the only ones present were haemopty-
sis, unintentional weight loss and persistent cough lasting longer than 
6 weeks, although weight loss might be indicative of any tumour type. 
Other important signs identified during the FGDs included persistent 
hoarseness, and disturbed sleep caused by any of the other symptoms.
General practitioners described that while some patients were fre-
quent attenders, others rarely if ever consulted GPs whatever symp-
toms they experienced. As the extract below illustrates, GPs in two 
FGDs argued that patients who rarely consulted the practice but then 
suddenly reported symptoms should trigger a high level of GP concern, 
irrespective of specific symptoms.
GP1: One of the biggest red flag symptoms for me when 
somebody comes to see me for anything are the people 
who never come to the surgery.
GP2: Absolutely.
GP1: Out of any of the symptoms, that is always more 
of a red flag to me than cough, breathlessness, and hae-
moptysis. If they hadn’t been in for years and then even if 
it’s something quite minor, I would investigate everything 
there and then. (FGD 3)
3.3 | Investigating patients for lung cancer
Several GPs believed that in the absence of definitive symptoms pre-
sented by patients, their gut instinct was their most valuable tool when 
deciding to investigate for lung cancer. All GPs agreed they required 
a relatively low threshold of suspicion before referring patients with 
potential symptoms of lung cancer for CXRs. This would especially be 
the case for unexplained symptoms listed in the NICE guidelines, but 
might include others given the specific clinical history of a patient.
GP1: We’ve had it drummed into us, £20 for a chest X- ray, 
then you get more radiation sat in a rock in Cornwall, so 
we’re just told if in doubt, X- ray.
GP2: And if in doubt repeat your X- ray. That’s been 
drummed into us again and again of course by the chest 
physicians, don’t be afraid to do chest X- rays, it’s an easy 
test and it’s cheap, low risk. (FGD 4)
Nevertheless, CXRs were perceived as blunt instruments and concern 
existed amongst GPs regarding the optimum timing of this investigation. 
Several participants were concerned that CXRs were often insufficiently 
sensitive to identify a lung tumour until quite large, and possibly inoper-
able. At the same time, as the GPs in the following extract argue, if CXRs 
were conducted when the mass was too small to be detected, then the 
negative result may serve as a false sense of security for both patient 
and GP.
GP1: And [patients] have not come back, because they’ve 
had a chest x- ray and that’s a false reassurance, it is about 
getting the time right.
GP2: I’ve had one in my career come back who we’d done 
a chest X- ray fairly early on, and they came back about 
6 months later with basically a consolidation on one side, 
and it had just completely obstructed. But they’d gone 
away because they’d had that reassuring chest X- ray.
GP1: There is the danger of false reassurance, because 
you’ve had the symptom constellation, you’ve gone and 
had your chest X- ray, the chest X- ray’s normal, the doc-
tor told me my chest X- ray’s normal, I haven’t got cancer, 
I won’t go back if my cough continues, or actually I’ve 
coughed up a little bit of blood but I know my chest X- ray 
was normal so. It is about the timing of that intervention, 
and acceptance that the chest X- ray is not, …, it’s far from 
a perfect test. (FGD 1)
Given these perceived limitations, participants from three FGDs ar-
gued GPs should have greater access to diagnostic tools such as com-
puted tomography (CT). The GPs in the following extract argued that if 
they were to conduct a CT prior to referral to secondary care they would 
have greater confidence in their referral and it may also reduce time to 
diagnosis.
GP1: We often say to [patients], don’t be put off if there’s 
nothing on your first x- ray, and to come back six weeks 
later if you’re still worried and we’ll do another one. That’s 
again where I come back to that thing about access to 
CT scanning. By the time we’re diagnosing them by CXR 
they’re pretty big.
GP2: And the CXR misses quite a few.
GP1: Yes. The first thing the [specialist] respiratory team 
are going to do is [CT] scan them. If we had access we 
could do this and then only refer those that were really a 
concern. It would make the process clearer for us and cost 
the system less. (FGD 4)
6 of 8  |     WAGLAND et AL.
Agreement about direct access to CT scanning was not universal, 
however, with some GPs indicating false negatives were similarly pos-
sible or that referring patients for CTs prior to secondary referral could 
slow rather than speed the process.
Despite the reportedly low threshold of suspicion to conduct a 
CXR, several GPs were less certain as to how they would proceed if 
the CXR result were inconclusive but symptoms persisted. As the fol-
lowing extract shows, a higher threshold of evidence appeared nec-
essary for most GPs before referring patients to specialist secondary 
care teams, partly due to a concern that the system would sink if they 
referred all patients about whom they had low level suspicion.
GP1: It’s a big step for us to then refer them on, and say, I 
know this chap’s a smoker and he’s got a persistent cough, 
his bloods are normal, his chest X- ray shows nothing, I’d 
be grateful if you could exclude a lung cancer. We don’t do 
many of those do we?
GP2: It’s expected that we wouldn’t, but if you went to a 
clinical meeting, that’s not what the consultant exactly 
would say. But the system would sink in a week if we did 
that, it’s just not what we do, but we’d have trouble defend-
ing that probably. So yes we’d be told, if the cough goes on, 
if the chest X- ray’s normal, then you probably should refer 
them on to us, but if we did that with them all, they don’t 
realise the size of the problem in general practice.
GP3: I think there is a misconception isn’t there, from 
[what] the hospitals think our workload is in respect to 
cough, persistent cough, and well, all the [lung cancer] 
symptoms. (FGD 4)
3.4 | Potential for early diagnosis
Opinions differed amongst GPs with regards the potential for effec-
tively increasing earlier diagnosis of lung cancer. While participants 
within all FGDs believed measures to identify symptoms of lung can-
cer at an early stage were necessary to offer patients greater oppor-
tunities for survival and quality of life, participants within two FGDs 
were pessimistic of their potential effectiveness. Moreover, while 
acknowledging the success of the national awareness “three- week 
cough” campaign in 2012, almost all GPs expressed concerns regard-
ing large perceived increases in patient consultations triggered by the 
campaign, over which practices had no control.
GP1: I quite like the idea of targeted screening. It appeals 
to me more than national campaigns because, again, na-
tional screening on the whole gets the worried well and 
just worries them more. Targeting those who ignore the 
national screening is a much better idea.
GP2: Particularly when you’ve got something like lung can-
cer …
GP1: But when you think about the amount of funding 
that must go into national campaigns. So if a slice of that 
came down to actually targeted screening, I imagine it 
could be so much more cost- effective.
GP2: Something like that might work, but until you’ve tried 
it and crunched the numbers. But that would feel a bit 
more appropriate than this across the board [campaigns], 
because as [GP1 name] says, you can be guaranteed it’s the 
worried well that come and snarl up the system. (FGD 5)
General practitioners considered symptoms indicative of lung cancer 
highly prevalent amongst older smokers/ex- smokers, who often have 
associated comorbidities (ie, COPD, asthma). GPs argued viral chest in-
fections often manifested with patients coughing for more than 3 weeks, 
and considered clinical histories, GP “hunches” and previous consulting 
behaviour as compelling as the presence of particular symptoms to 
identify suspected lung cancer. Consequently, participants were con-
cerned that interventions should not simply target specific symptoms. 
Furthermore, participants favored practice- level initiatives, where GPs 
and practice nurses identified patients with particular risk profiles, as 
potentially both as effective and cost effective as targeting single symp-
toms within the general population.
GP1: Thinking about my morning clinic, I was seeing pa-
tients with four of these [potential lung cancer] symptoms, 
but I haven’t gone down the route of thinking lung cancer.
GP2: There is a risk we would generate workload that we 
wouldn’t be able to cope with, and have a knock on risk of 
our other patients.
GP3: It’s about stopping the flood gates opening.
GP1: It’s not necessarily symptoms we should be targeting, 
anyway. It’s particular patients. (FGD 3)
However, participants broadly agreed that whatever form targeted 
interventions took, a core of people are not going to come whatever you do.
4  | DISCUSSION
Limited work has previously investigated GP’s views of their own role 
in early detection (Green, Atkin, & Macleod, 2015). This study con-
ducted focus groups with GPs from participating general practice sites 
to elicit their views with regards facilitating targeted interventions. 
Participant GPs identified what they perceived as the three most rel-
evant symptoms for diagnosing possible lung cancer as: recent, sig-
nificant weight loss; persistent cough for longer than 6 weeks; and 
haemoptysis. There was no consensus between FGDs on those symp-
toms most indicative of early lung cancer. Previous research has found 
that lung cancer symptoms may be experienced only as vague or mild 
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(Smith, Pope, & Botha, 2005), may be confounded by high levels of co-
morbidities (Stolper et al., 2011), and patients subsequently diagnosed 
with lung cancer reported good health prior to diagnosis (Brindle et al., 
2012). Studies have shown patients with lung cancer commonly ex-
perience multiple and synchronous symptoms (Hamilton et al., 2005; 
Walter et al. 2015), and may be symptomatic for many months be-
fore presentation (Corner, Hopkinson, Fitzsimmons, Barclay, & Muers, 
2005). Thus, patients are often unable to recognise all their symptoms 
(Smith et al., 2009), appraise symptoms as not warranting help- seeking 
(Corner & Brindle, 2011), or else normalise symptoms, attributing their 
cause either to ageing processes or comorbidities (Corner et al., 2005; 
Tod & Joanne, 2010). Members of this research team have previously 
argued that to better elicit lung cancer symptoms, GPs may need to 
ask patients closed questions using non- disease terminology (Brindle 
et al., 2012).
General practitioners emphasised that clinical histories and GP 
“hunches” were as important as specific symptoms in identifying pa-
tients who should be further investigated for lung cancer (Stolper et al., 
2011). GPs also argued that symptomatic patients who rarely attended 
the practice, irrespective of their presenting symptoms, would trigger 
their concern. The CAPER studies and QCancer algorithms have pro-
vided risk prediction models for cancer types, including lung cancer 
(Hamilton, 2009; Hippisley- Cox & Coupland, 2011). However, of a 
sample of patients who subsequently developed lung cancer, between 
17% and 34% of symptoms presented in the previous 24 months were 
not caused by the cancer (Biswas, Ades, & Hamilton, 2015). Also, while 
hemoptysis is the strongest symptom predictor of lung cancer, only a 
fifth of patients experience it (Walter et al., 2015).
In response to symptoms, GPs reported they required low thresh-
olds of suspicion of lung cancer before referring patients for CXRs; 
the standard initial investigation for symptoms indicative of lung 
cancer (NICE, 2005; NICE, 2011; NICE, 2015). Nevertheless, GPs 
expressed limited confidence in the diagnostic capacity of CXRs, and 
previous studies found few CXRs identified signs of lung cancer in 
patients 6 months or more prior to their actual diagnosis (Hamilton 
et al., 2005; Stapley, Sharp, & Hamilton, 2006). Uncertainty also 
existed amongst GPs regarding both how best to proceed if a pa-
tient’s symptoms persist despite a negative CXR, and the level of 
suspicion appropriate before specialist respiratory referral should be 
made. The recently revised NICE guidance for suspected cancer re-
ferrals has reduced the expected probability threshold for a cancer 
diagnosis to trigger a secondary referral, from the previous predic-
tive and prognostic value (PPV) threshold of approximately 5%–3% 
(NICE, 2015). Effectively, this means an extension in the number of 
patients needed to be referred (NNtR) for one cancer diagnosis from 
approximately 20 to 33. Nevertheless, GPs felt pressure not to refer 
patients with vague symptoms on to specialist secondary care with-
out sufficient diagnostic evidence, and cited concern for “system 
overload”. It is therefore unclear how GPs will respond to a lower 
PPV threshold for cancer referrals and whether the guideline change 
will result in any meaningful behaviour change, hence referrals might 
remain restricted at practice level. Further research should explore 
whether and how GPs utilise the reduced PPV threshold. Although 
some GPs were ambivalent about greater access to additional di-
agnostic procedures such as CT, others argued it would give them 
greater confidence in the PPV of suspected lung cancer cases, better 
facilitating timely diagnosis. Investigating this potential is another 
area for future work.
While acknowledging the impact of the “3- week cough” cam-
paign, GPs argued such national initiatives often heightened demand 
on limited resources, but may have little impact upon those patients 
most at risk who ignore them. The existence of a symptomatic, non- 
consulting group of primary care patients identified by our wider 
study would support this view (Wagland et al., 2016). Although the 
“3- week cough campaign” led to a 9% increase in lung cancer diagno-
ses compared with the same period in the previous year (Ironmonger 
et al., 2015), there was a corresponding increase of >200,000 addi-
tional GP attendances and 30% increase in 2- week waits recorded 
(PULSE 2014). Evidence also indicates such increases are particularly 
apparent in affluent rather than deprived areas (Green et al., 2015). 
All GPs in our sample recognised the importance for seeking methods 
for timely diagnoses of lung cancer, despite concerns about increased 
workloads. GPs within all FGDs agreed interventions targeting pa-
tients at high- risk of lung cancer and who rarely attend primary care, 
might be at least as effective and cost- effective as targeting specific 
symptoms. Potential methods, given this study’s findings, would in-
clude practice- level interventions that allowed GPs control over iden-
tifying and contacting “high- risk” patients, facilitating planning for 
subsequent workload increases. Further work is needed to identify 
profiles of primary care patients who would benefit most from such 
targeted interventions.
4.1 | Strength and limitations
Participant GPs had a broad range of experience (mean: 19 practice 
years), represented practices of different sizes, with both high and low 
levels of social deprivation, in both rural and urban settings, and con-
sensus existed across FGDs on most themes.
5  | CONCLUSION
General practitioners questioned current approaches to promoting 
earlier diagnosis through national campaigns. Given the problem-
atic “symptom signature” and corresponding difficulties for both 
GPs and patients to recognise symptoms of lung cancer, future 
interventions promoting early diagnosis of lung cancer should in-
clude the targeting of “high- risk” individuals. Some GPs also argued 
for greater access to more sensitive diagnostic investigations, in 
particular CT scans, to enhance the PPV of secondary referrals. 
Allowing GPs to target “at- risk” patients on their lists would allow 
them to plan for the more limited workload increases these would 
entail compared with large national symptom campaigns over 
which they have limited control. Further work is required to iden-
tify primary care patients who would most benefit from such tar-
geted interventions.
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